601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours

Detalles Bibliográficos
Autores principales: Gelderblom, H., Gietema, J.A., Desar, I.M.E., Ajmone, N.M., Jalving, M., Kroep, J.R., Nicolas, V., Vaslin, A., Tobal, K., Purcea, D., van Haren, S.F., Damstrup, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506497/
http://dx.doi.org/10.1016/j.annonc.2020.08.715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506497/
http://dx.doi.org/10.1016/j.annonc.2020.08.715

Ejemplares similares